863492-49-3

Basic information

• Product Name: (S)-{[(4-fluorobenzyl)methylcarbamoyl]phenyl-methyl}carbamic acid tert-butyl ester
• Synonyms: (S)-{[(4-fluorobenzyl)methylcarbamoyl]phenyl-methyl}carbamic acid tert-butyl ester
• CAS NO: 863492-49-3
• Molecular Weight: 372.44
• Mol File: 863492-49-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (S)-{[(4-fluorobenzyl)methylcarbamoyl]phenyl-methyl}carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-{[(4-fluorobenzyl)methylcarbamoyl]phenyl-methyl}carbamic acid tert-butyl ester(863492-49-3)
• EPA Substance Registry System: (S)-{[(4-fluorobenzyl)methylcarbamoyl]phenyl-methyl}carbamic acid tert-butyl ester(863492-49-3)

Safety Data

• Hazardous Substances Data: 863492-49-3(Hazardous Substances Data)

Upstream product

• 405-66-3 (4-Fluoro-benzyl)-methyl-amine 
• 2900-27-8 (2S)-2-[(tert-butoxycarbonyl)amino]-2-phenylethanoic acid 

Downstream Products

• 863492-50-6 (S)-2-amino-N-(4-fluorobenzyl)-N-methyl-2-phenylacetamide hydrochloride 

Relevant articles and documents

HETEROCYCLYLAMIDES AS GUT MICROSOMAL TRIGLYCERIDE TRANSPORT PROTEIN INHIBITORS

Compounds represented by formula (I) are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with patients are risk for developing such diseases or conditions.

SUBSTITUTED QUINOLINE COMPOUNDS

This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.